Therapy Market Research Reports & Industry Analysis

... size ... Peptide & Insulin “Global Peptide Therapeutics Pipeline Insight 2015” Report Highlights: Global Peptide Therapeutics Market Overview Global Peptide Therapeutics Pipeline By Peptide Type Global Peptide Therapeutics Pipeline By Company, Indication & Phase Peptide Therapeutics Clinical Pipeline: 743 Peptides ...

Innovative Therapies for treating diseases ... interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being ... coverage in our Outlook this year. Key Criteria for Our Selection are:- Uniqueness of the Technology platform and the ability ...

... titled “Global Acne Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the acne market with focus on global prescription drugs. The report assesses the market sizing ... laser treatment for acne, technology driven products are the key trends of the acne industry. However, with immense growth opportunities, the global acne market faces the ...

... of novel delivery technologies employed in the formulation of abuse deterrent product, technologies employed in enhancing patient compliances and emerging novel mechanisms in the management of pain. Renewed interest on pain therapy ...

... Proton Therapy Market Opportunity Analysis” Report Highlight: US Proton Therapy Market Overview Targeted Patient Base & Economic Capacity Analysis Proton Therapy Cost Analysis Proton Therapy Reimbursement Policy Proton Therapy Center Infrastructure Analysis US Proton Therapy Market ...

Peptide Therapeutics Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files. Each ...

... a comprehensive assessment of the fast–evolving, high–growth of United States Pain Management Therapeutics Sector. This 73 page report with 46 Figures and ... the basis of: I. United States Pain Management Therapeutics Market from the year 2005 – 2018 II. United States Pain Management Patients Population from ...

... ? Multiple Sclerosis – Oral therapy takes centre stage is a comprehensive Therapy Trends report packed with knowledgeable opinions and insights of 12 leading US and European KOLs on current ... , MD, is a preeminent MS clinician at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Co-Director, Multiple Sclerosis Care Center, Maimonides Medical Center Dr Robert Naismith, MD, Assistant Professor ...

... can be prevented. “UAE IVF Treatment Market Outlook 2018” Report Highlights: Current Market Scenario IVF Treatment Market Potential Treatment cycle & Birth Rate Fertility Treatment Loan Facility Regulations for Licensing of Fertilization Centers Medical ...

... make it more accessible to patients. According to the “US Proton Therapy Outlook: Market Opportunities”, by RNCOS, the United States will be home to almost 29 such centers ... size and its future condition. After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges which ...

... benefit/positioning and support patient initiatives. Payer Insights: Hepatitis C, based on in-depth interviews with 12 leading healthcare payers in the US, is packed with hard-hitting, candid ... been matched by the opposition of healthcare payers at the cost. This report gives insights into what US healthcare payers really think about HCV drug ...

The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and ... , various antifungal agents with novel action mechanisms, broader action spectrum and fewer side effects have emerged. Growth within global antifungal therapeutics market is driven ...

... neurologists to ascertain how practising physicians currently view and evaluate the gene therapy development space. Specifically we are asking them... How familiar they are with ... What they perceive to be the key benefits of gene therapy? What are their specific concerns with gene therapy? What is the highest ...

... a biologic therapy? Whether, and to what extent, quality-of-life measures will be more important than secondary efficacy measures for differentiating new biologic therapies for severe asthma? What level of advantage, if any, reduced dosing frequency would provide for a biologic severe asthma ...

... centers that have been established globally. According to our report, “Global Proton Therapy Outlook 2018”, 16 such centers have been established ... capacity of existing centers and those that are expected to come up by 2018. In the Geographic Assessment section, we have provided a detailed analysis of four ...

... titled “Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global aortic aneurysm repair market with major focus on more prevalent endovascular abdominal aortic aneurysm repair. The report also provides detailed analysis of aortic aneurysm market in major regions ...

... for more proton therapy centers are very high. This report is divided into 14 Chapters A. United States Proton Therapy Market – Actual ... IBA Proton Therapy 2. Optivus Proton Therapy 3. Hitachi Proton Therapy 4. Mevion Proton Therapy 5. Varian Proton Therapy Chapter No. 11 speaks of Proton Therapy centers ...

... and in industry. Since discovery, RNA interference is considered to be a turning point for molecular ... Global RNAi Therapy Report Highlights: Introduction & Need Analysis of RNAi Therapy Benefits & Drug Delivery Mechanics Related to RNAi RNAi Therapy Market Insight Ongoing Clinical Trail/Pipeline for RNAi ...

There are more than 1400 sustained or controlled release drugs have been approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of overall ...

Over the last decades, therapeutic options for Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA) have expanded ... OTEZLA – apremilast, Xeljanz – tofacitinib) and onwards. In this report, we highlight the novel targets – oral, injectables, and topical drugs in the pipeline for the treatment of Psoriasis ...

... decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomodulatory drugs – Thalomid (thalidomide) and Revlimid (lenalidomide) have become the cornerstone of treatment for patients with Multiple Myeloma (MM) resulting ...

... map for biosimilars space, at this time we see Sandoz, JCR, Meiji Seika Pharma, Fuji Film Kyowa Kirin Biologics, Nippon Kayaku, Nichi Iko, Yoshindo etc. to be amongst the key players in biogenerics business in Japan. It is also noteworthy ...

... infections during the treatment were not available. If that fails, the gains ... super infections” warranting need for new classes of antibiotics and other preventive/therapeutic approaches ... Gram Negative infections and CRE. Pipeline of novel targets being used to develop new drugs to treat infections and resistance ...

... bigger for newer options than late stage if they succeed.In coming years, we expect second generation antiandrogens (Androgen synthesis inhibitors/Androgen receptor inhibitors, Xtandi, ARN-509, ODM-021, Zytiga, TAK-700, TOK-001) to replace ...

... in the pre-clinical studies. There are many applications of the peptide drugs. The most popular and dominant segments include cancer ... demand for peptide drugs, this market is expected to grow at a CAGR of 9-10% to reach approximately USD 27.3 billion by 2018. “Global Peptide Therapeutics Market & Pipeline ...

... lymphocytic/lymphoblastic leukemia may also occur in adults. The acute lymphocytic/lymphoblastic leukemia market is segmented into two types—childhood acute lymphocytic/lymphoblastic leukemia and adult acute lymphocytic/lymphoblastic leukemia. The acute lymphocytic/lymphoblastic leukemia therapeutics market ...

... is increasing at an alarming rate. According to RNCOS’ report “Booming IVF Market in India”, the IVF market is poised to witness impressive CAGR of around 14% over ... region-wise i.e. their penetration across East/West/North/South India; their structure i.e. chain, independent and hospital-based; the number of ...

... IUI, IVF, and ICSI (intra cytoplasmic sperm injection). India has become one of the favored destinations for infertility treatments such as IVF due to several ... health care system. “India IVF Treatment Market Outlook 2018” report by KuicK Research gives comprehensive insight on following aspects related to booming IVF treatment market in India: Market Overview IVF Treatment Market Potential Total Fertility ...

... Scope of the report The report titled “Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)” provides an in-depth analysis of global rheumatoid arthritis market with special focus on biologics drugs. It also accesses the key opportunities and underlying trends in the market and outlines the ...

... report titled “Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)“ provide an insight into the market dynamics and various trends and opportunities associated with the global multiple sclerosis market. The report ... contributor to the global multiple sclerosis market has been assessed. The report concludes with a brief discussion of major factors driving the global multiple sclerosis market and profiles major ...

... Report The report titled “Global Age-Related Macular Degeneration (AMD) Market: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global age-related macular degeneration market with detailed analysis of various ... Age-related macular degeneration (AMD) is a condition affecting older people, and involves the loss of the person's central field of vision. Several forms of AMD exist such as early AMD ...

... Xeljanz to gain approval in Europe (see ViewPoints: Key opinion leader casts doubt as to whether Pfizer's Xeljanz ... Xeljanz's ability to inhibit progression of structural disease. FirstWord polled US-based rheumatologists in May to ascertain how physicians were utilising Xeljanz and this week's Physician Views ...

... survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the ... selective without the need for any genetic manipulation. “Global Oncolytic Virus Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...

... report titled “Global Testosterone Therapy Market”: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global Testosterone Therapy market with detailed analysis of symptoms, diagnosis and treatment of testosterone deficiency. The report majorly focuses on the US testosterone therapy market and also assesses ...

... or ribavirin, thus significantly reducing side-effect burden. A Physician Views poll run by FirstWord in December 2012 (among 74 US-based gastroenterologists ... one-tablet combination of sofosbuvir and ledipasvir). But what of its commercial opportunity in the meantime, assuming the drug is launched in ...

... to make it more accessible to patients. According to the “US Proton Therapy Outlook 2017” by RNCOS, the United States will be home to almost 27 such centers ... will breach the Billion dollar mark to attain revenue of US$ 1.17 Billion by 2017. The following 65 pages report provides an insight into the cancer ...

The Competitive Intelligence report Smallpox Vaccines & Therapeutics as of August 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics for prophylaxis of Variola virus infection and treatment of smallpox. Purchase of the pdf report includes a 6-month online ...

... to boost the growth. According to RNCOS’ new research report, “Global Gene Therapy Market Analysis”, major focus has been made on the ongoing ... therapy include cardiac conditions, genetic disorders and neurological diseases. An effective analysis of the key therapeutic areas has been included in the report. ...

... undisclosed settlement dates, based on available facts. In other words, Para IV Plus is not merely a database but is a tool with in-depth insights for every ... gives list of potential API buyers To a pharma company desirous of banking on the Para IV litigations, this tool will help them strategize their entry ...

Pricing: Japan Database: $15,000/- subscription p/a Formulating a competitive landscape of various therapeutic classes in Japan is challenging viz a viz the US and EU markets ... reliable Source in public domain 5. Large contribution of ‘Japan Only’ products - difficult to make competitive landscapes for overseas ...

Endocyte’s (ECYT) SMDC technology platform and drug pipeline caught investor’s ... our initiation report released on 19th April, 2013 on ECYT titled “Small and Powerful Targeted Therapy!

... titled ‘Global Irritable Bowel Syndrome Market: Trends and Opportunities (2012-17)’ provides an in depth analysis of IBS market on a global level. The report presents the global market sizing of IBS and ... Sucampo Executive Summary Irritable Bowel Syndrome or IBS is a gastrointestinal disorder in which the colon muscle contracts more readily. The high prevalence of this syndrome could be estimated ...

... one of the highest impact rendering drivers of the multiple sclerosis therapeutics market. Many organizations over the globe are actively involved in ... high prescription rates & price North America dominated the overall multiple sclerosis therapeutics market with revenue estimates at over 13.0 billion in 2015. ...

... be prevented. “UAE IVF Treatment Market Analysis” research report gives detailed information on following aspects related to booming IVF treatment market in UAE: Current Market Scenario IVF Treatment Market Potential Treatment cycle & Birth Rate Fertility Treatment Loan ...

... FirstWord research is provided in two comprehensive modules: The KOL Insight: HIV module provides a complete review underpinned by exclusive in-depth interviews with ... Protease inhibitors CCR5 inhibitor Expert Opinion for Real World Insights The data and analysis in the report is enriched through the ...

... GLP-1 secretion in glucose depended manner is the key trait of this class. Through this, GPR agonist controls hyperglycemia without hypoglycemia, and ...

Hemophilia is an inherited (X-linked recessive trait), lifelong bleeding disorder that prevents blood from clotting due to insufficient or lack of adequate amount of clotting factors – Factor VIII (FVIII) and Factor IX (proteins in blood that control bleeding). Plasma-derived FVIII and FIX proteins were used ...

... Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies and of enzyme enhancement therapies to treat human genetic diseases/lysosomal storage diseases and exocrine pancreatic ...

Charting the Future Multiple Sclerosis Market LandscapeOver the next five years, the global multiple sclerosis (MS) market is set to grow from $12.3 billion in 2011 to $17.3 billion in 2016. Primary d...

... of QVA-149 from fifth and final successful pivotal clinical study result (SPARK) from IGNITE program on August 30th, 2012. The fixed dose LABA ... in the US and 2012-2013 in the EU and hence any market share loss would be immaterial from Pfizer perspective. The LABA/LAMA FDC will also ...